The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution
about
Crystal structure of a human aminoacyl-tRNA synthetase cytokineFunctional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structureHuman Macrophage Inflammatory Protein 3 : Protein and Peptide Nuclear Magnetic Resonance Solution Structures, Dimerization, Dynamics, and Anti-Infective PropertiesStructure of mouse IP-10, a chemokineA Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional EffectsStructural characterization of a monomeric chemokine: monocyte chemoattractant protein-3The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactionsCrystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptorIdentification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimerThrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.Overview of protein structural and functional folds.Overview of protein folds in the immune system.Chemical modification of a variant of human MIP-1alpha; implications for dimer structureEvidence for a granule targeting sequence within platelet factor 4.Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan InteractionsStructural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™Structural diversity of heparan sulfate binding domains in chemokinesHomology modeling and molecular dynamics simulations of lymphotactin.Structural perspectives on antimicrobial chemokines.A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer.Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer.Chemokine oligomerization in cell signaling and migration.Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan HeparinNative thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.Exploring platelet chemokine antimicrobial activity: nuclear magnetic resonance backbone dynamics of NAP-2 and TC-1.NMR structure and dynamics of monomeric neutrophil-activating peptide 2.Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil-Platelet Crosstalk.Glycosaminoglycan Interactions Fine-Tune Chemokine-Mediated Neutrophil Trafficking: Structural Insights and Molecular Mechanisms.Dynamics and thermodynamic properties of CXCL7 chemokine.Stimulation of Cellular Sphingomyelin Import by the Chemokine Connective Tissue-activating Peptide III
P2860
Q24539028-73D3E08E-0EA8-4D5E-9F8C-1BC07C185DDCQ24673393-5361209C-1029-4D9D-952D-ED4B44EC54C0Q27631819-FBC5BAA8-AAC4-4AFD-A1AC-B9BBE40F51D5Q27649353-951CA13F-D43D-4620-9A4D-400EB053584EQ27650864-176E0851-19FB-413C-B158-C2B29AAAF721Q27681101-9FF59F2C-825F-4704-9B46-E18CBCC9494BQ27733787-5053D83B-BB47-486E-892C-7ADAFBB27588Q27734322-D7298AED-2A33-4095-BCBE-7FA8ABB932C9Q27758437-EA5B0B42-5B40-4AE3-9E55-E3990A9F1753Q28207703-15AE122B-B31E-462A-839A-83F67F9001B6Q29871535-4B481396-11B5-40EB-9C96-854289640C8BQ30368988-13FC1237-98C3-4DF3-ACE2-3748C54DCA72Q30369011-9A6C74BA-755D-4C7B-B3DE-0E168052DDEFQ30975489-9C5989AC-88F2-4A9C-887A-DACA54E2806FQ33217394-7BD697F1-6762-4827-B4C1-E637B3F597D0Q33624473-C5937D07-DB92-4110-B1CD-5E75DB91A0B4Q33649788-1946F122-4206-4839-AC19-2C8AA0051A6DQ34008721-2E744D89-EC07-48B8-8B9E-CAD1EE570E99Q36281781-AE373EBD-097D-4C51-8735-65F0E91BFF20Q36492362-68CBFFEB-F55F-40E2-98AE-3E23C2C06953Q36554378-ABE7C0CE-CEEB-4938-9D58-A68C98E8EB62Q37132063-F0D1FC98-767A-4F3E-998B-177D76E6CA67Q37608845-D1CAA902-CC8B-464A-BE8B-0CD43DF33B3FQ37729038-50B8C9AD-344C-4C56-9445-420F70F51860Q39709081-BA565DE8-91F2-495A-BD88-175B47379DE8Q41852391-3548CECC-C944-498A-B89A-0674300C806DQ42182987-E9EFE58B-7284-41BD-8609-A3F50FE0CF63Q42371900-8A0B6A57-4C57-44D6-8EE6-C2BA8A271953Q49381966-8AB89B2D-3590-4DA5-8C27-2A1B596A8AB2Q51799173-4A55A502-CCBA-4121-B845-F7F4367E08CCQ57371898-B3480A51-5A1E-45C5-BB13-295C737D585B
P2860
The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@ast
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@en
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@nl
type
label
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@ast
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@en
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@nl
prefLabel
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@ast
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@en
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@nl
P2093
P2860
P356
P1476
The crystal structure of recom ...... de-2 (M6L) at 1.9-A resolution
@en
P2093
B F Edwards
M G Malkowski
P H Johnson
P2860
P304
P356
10.1074/JBC.270.13.7077
P407
P577
1995-03-31T00:00:00Z